Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts [PDF]
, 1979 AA Fauser, HA Messner
openalex +1 more source
Inflammatory cytokines and venous thrombosis bidirectional causal correlations: A Mendelian randomization study. [PDF]
Medicine (Baltimore)Zhou H +5 more
europepmc +1 more source
Alteration of the Cell Periphery During Granulocyte Maturation: Relationship to Cell Function [PDF]
, 1972 Marshall A. Lichtman, Robert I. Weed
openalex +1 more source
Use of postpheresis plasma to improve granulocyte yields for transfusion [PDF]
, 1975 AJ Roy, A Brivkalns, RA Yankee
openalex +1 more source
Formulation and In Vitro Characterization of Granulocyte-Colony-Stimulating-Factor-Loaded Liposomes: Future Prospective in Reproductive Medicine. [PDF]
Int J Mol SciObedkova KV +5 more
europepmc +1 more source
Targeting the Menin–KMT2A interaction in leukemia: Lessons learned and future directions
International Journal of Cancer, EarlyView.Abstract Chromosomal rearrangements involving the Mixed Lineage Leukemia gene (MLL1, KMT2A) are defining a genetically distinct subset in about 10% of human acute leukemias. Translocations involving the KMT2A‐locus at chromosome 11q23 are resulting in the formation of a chimeric oncogene, where the N‐terminal part of KMT2A is fused to a variety of ...
Florian Perner +3 more
wiley +1 more source
Mediation Mendelian randomization analysis of immune cell phenotypes and glioma risk: unveiling the regulation of cerebrospinal fluid metabolites. [PDF]
Discov OncolZhao S, Jiang J, Zhang J, Jin X.
europepmc +1 more source
Antibacterial activity of cationic proteins from human granulocytes. [PDF]
, 1975 Håkan Odeberg, Inge Olsson
openalex +1 more source
Lipocalin‐2 ameliorates granulocyte functionality
European Journal of Immunology, 2012 Andrea Schroll +8 more
semanticscholar +1 more source
International Journal of Cancer, EarlyView.What's New? While melanoma vaccines have shown therapeutic promise, predicting their clinical benefits is challenged by factors such as delayed response to immunotherapy and scarcity of biomarkers. Here, the authors examined the long‐term efficacy of vaccination with either 4 or 12 class I MHC‐restricted peptides in high‐risk melanoma.
Emily K. Ninmer +3 more
wiley +1 more source